Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent. | Mol Oncol | 2022 | 35278276 | PubTator, text mining | PubMed |
| The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling. | J Immunother Cancer | 2022 | 35277457 | PubTator, text mining | PubMed |
| Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women. | Cells | 2022 | 35269469 | PubTator, text mining | PubMed |
| The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. | Cancers (Basel) | 2022 | 35267668 | PubTator, text mining | PubMed |
| Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients. | Cancers (Basel) | 2022 | 35267598 | PubTator, text mining | PubMed |
| Circulating immune cell landscape in patients who had mild ischaemic stroke. | Stroke Vasc Neurol | 2022 | 35264400 | PubTator, text mining | PubMed |
| Intranasal delivery of inactivated PRRSV loaded cationic nanoparticles coupled with enterotoxin subunit B induces PRRSV-specific immune responses in pigs. | Sci Rep | 2022 | 35260663 | PubTator, text mining | PubMed |
| Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. | Hepatology | 2022 | 35243668 | PubTator, text mining | PubMed |
| Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma. | Cell Rep Med | 2022 | 35243413 | PubTator, text mining | PubMed |
| Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival. | J Immunother Cancer | 2022 | 35217577 | PubTator, text mining | PubMed |
| Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response. | Int J Mol Sci | 2022 | 35216427 | PubTator, text mining | PubMed |
| Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System. | Viruses | 2022 | 35215970 | PubTator, text mining | PubMed |
| Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence. | Viruses | 2022 | 35215783 | PubTator, text mining | PubMed |
| Adaptive Cellular Immunity against African Swine Fever Virus Infections. | Pathogens | 2022 | 35215216 | PubTator, text mining | PubMed |
| Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial. | Vaccines (Basel) | 2022 | 35214798 | PubTator, text mining | PubMed |
| Plant-Based Vaccines in Combat against Coronavirus Diseases. | Vaccines (Basel) | 2022 | 35214597 | PubTator, text mining | PubMed |
| The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach. | Cancers (Basel) | 2022 | 35205782 | PubTator, text mining | PubMed |
| Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival. | Cancer Immunol Res | 2022 | 35201289 | PubTator, text mining | PubMed |
| Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia. | Sci Transl Med | 2022 | 35196021 | PubTator, text mining | PubMed |
| Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35193632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=31